Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2016

Open Access 01-12-2016 | Research article

E2 regulates MMP-13 via targeting miR-140 in IL-1β-induced extracellular matrix degradation in human chondrocytes

Authors: Yujie Liang, Li Duan, Jianyi Xiong, Weiming Zhu, Qisong Liu, Daming Wang, Wei Liu, Zigang Li, Daping Wang

Published in: Arthritis Research & Therapy | Issue 1/2016

Login to get access

Abstract

Background

Estrogen deficiency is closely related to the development of menopausal arthritis. Estrogen replacement therapy (ERT) shows a protective effect against the osteoarthritis. However, the underlying mechanism of this protective effect is unknown. This study aimed to determine the role of miR-140 in the estrogen-dependent regulation of MMP-13 in human chondrocytes.

Methods

Primary human articular chondrocytes were obtained from female OA patients undergoing knee replacement surgery. Normal articular chondrocytes were isolated from the knee joints of female donors after trauma and treated with interleukin-1 beta (IL-1β). Gene expression levels of miR-140, MMP-13, and ADAMTS-5 were detected by quantitative real-time PCR (qRT-PCR). miR-140 levels were upregulated or downregulated by transfecting cells with a miRNA mimic and inhibitor, respectively, prior to treatment with IL-1β. MMP-13 expression was then evaluated by Western blotting and immunofluorescence. Luciferase reporter assays were performed to verify the interaction between miR-140 and ER.

Results

17-β-estradiol (E2) suppressed MMP-13 expression in human articular chondrocytes. miR-140 expression was upregulated after estrogen treatment. Knockdown of miR-140 expression abolished the inhibitory effect of estrogen on MMP-13. In addition, the estrogen/ER/miR-140 pathway showed an inhibitory effect on IL-1β-induced cartilage matrix degradation.

Conclusions

This study suggests that estrogen acts via ER and miR-140 to inhibit the catabolic activity of proteases within the chondrocyte extracellular matrix. These findings provide new insight into the mechanism of menopausal arthritis and indicate that the ER/miR-140 signaling pathway may be a potential target for therapeutic interventions for menopausal arthritis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pun YL, Moskowitz RW, Lie S, Sundstrom WR, Block SR, Mcewen C, et al. Clinical correlations of osteoarthritis associated with a single‐base mutation (Arginine519 to Cysteine) in type II procollagen gene. Arthritis Rheum. 1994;37:264–9.CrossRefPubMed Pun YL, Moskowitz RW, Lie S, Sundstrom WR, Block SR, Mcewen C, et al. Clinical correlations of osteoarthritis associated with a single‐base mutation (Arginine519 to Cysteine) in type II procollagen gene. Arthritis Rheum. 1994;37:264–9.CrossRefPubMed
2.
go back to reference Neugarten BL, Kraines RJ. “Menopausal symptoms” in women of various ages. Obstet Gynecol Surv. 1965;20:994–1001.CrossRef Neugarten BL, Kraines RJ. “Menopausal symptoms” in women of various ages. Obstet Gynecol Surv. 1965;20:994–1001.CrossRef
3.
go back to reference Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage. 2005;13:769–81.CrossRefPubMed Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage. 2005;13:769–81.CrossRefPubMed
4.
go back to reference Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778–99.CrossRefPubMed Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778–99.CrossRefPubMed
5.
go back to reference Sowers MR, McConnell D, Jannausch M, Buyuktur AG, Hochberg M, Jamadar DA. Estradiol and its metabolites and their association with knee osteoarthritis. Arthritis Rheum. 2006;54:2481–7.CrossRefPubMed Sowers MR, McConnell D, Jannausch M, Buyuktur AG, Hochberg M, Jamadar DA. Estradiol and its metabolites and their association with knee osteoarthritis. Arthritis Rheum. 2006;54:2481–7.CrossRefPubMed
6.
go back to reference Nadkar MY, Samant RS, Vaidya SS, Borges NE. Relationship between osteoarthritis of knee and menopause. J Assoc Physicians India. 1999;47:1161–3.PubMed Nadkar MY, Samant RS, Vaidya SS, Borges NE. Relationship between osteoarthritis of knee and menopause. J Assoc Physicians India. 1999;47:1161–3.PubMed
7.
go back to reference Turner AS, Athanasiou KA, Zhu C-F, Alvis MR, Bryant HU. Biochemical effects of estrogen on articular cartilage in ovariectomized sheep. Osteoarthritis Cartilage. 1997;5:63–9.CrossRefPubMed Turner AS, Athanasiou KA, Zhu C-F, Alvis MR, Bryant HU. Biochemical effects of estrogen on articular cartilage in ovariectomized sheep. Osteoarthritis Cartilage. 1997;5:63–9.CrossRefPubMed
8.
go back to reference Silberberg M, Silberberg R. Modifying action of estrogen on the evolution of osteoarthrosis in mice of different ages. Endocrinology. 1963;72:449–51.CrossRefPubMed Silberberg M, Silberberg R. Modifying action of estrogen on the evolution of osteoarthrosis in mice of different ages. Endocrinology. 1963;72:449–51.CrossRefPubMed
9.
go back to reference Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol. 1998;10:269–72.CrossRefPubMed Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol. 1998;10:269–72.CrossRefPubMed
10.
go back to reference Lotz MK, Kraus VB. New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res Ther. 2010;12:211.CrossRefPubMedPubMedCentral Lotz MK, Kraus VB. New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res Ther. 2010;12:211.CrossRefPubMedPubMedCentral
11.
go back to reference Wang M, Sampson ER, Jin H, Li J, Ke QH, Im H-J, et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther. 2013;15:R5.CrossRefPubMedPubMedCentral Wang M, Sampson ER, Jin H, Li J, Ke QH, Im H-J, et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther. 2013;15:R5.CrossRefPubMedPubMedCentral
12.
go back to reference Knäuper V, López-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem. 1996;271:1544–50.CrossRefPubMed Knäuper V, López-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem. 1996;271:1544–50.CrossRefPubMed
13.
go back to reference Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for estrogen receptors α and β in human articular chondrocytes. Osteoarthritis Cartilage. 1999;7:560–6.CrossRefPubMed Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for estrogen receptors α and β in human articular chondrocytes. Osteoarthritis Cartilage. 1999;7:560–6.CrossRefPubMed
14.
go back to reference Braidman IP, Hainey L, Batra G, Selby PL, Saunders PT, Hoyland JA. Localization of estrogen receptor β protein expression in adult human bone. J Bone Miner Res. 2001;16:214–20.CrossRefPubMed Braidman IP, Hainey L, Batra G, Selby PL, Saunders PT, Hoyland JA. Localization of estrogen receptor β protein expression in adult human bone. J Bone Miner Res. 2001;16:214–20.CrossRefPubMed
15.
go back to reference Sniekers Y, Weinans H, Bierma-Zeinstra S, Van Leeuwen J, Van Osch G. Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment–a systematic approach. Osteoarthritis Cartilage. 2008;16:533–41.CrossRefPubMed Sniekers Y, Weinans H, Bierma-Zeinstra S, Van Leeuwen J, Van Osch G. Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment–a systematic approach. Osteoarthritis Cartilage. 2008;16:533–41.CrossRefPubMed
16.
go back to reference Kinney R, Schwartz Z, Week K, Lotz M, Boyan B. Human articular chondrocytes exhibit sexual dimorphism in their responses to 17β-estradiol. Osteoarthritis Cartilage. 2005;13:330–7.CrossRefPubMed Kinney R, Schwartz Z, Week K, Lotz M, Boyan B. Human articular chondrocytes exhibit sexual dimorphism in their responses to 17β-estradiol. Osteoarthritis Cartilage. 2005;13:330–7.CrossRefPubMed
17.
go back to reference Lee YJ, Lee EB, Kwon YE, Lee JJ, Cho WS, Kim HA, et al. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes. Rheumatol Int. 2003;23:282–8.CrossRefPubMed Lee YJ, Lee EB, Kwon YE, Lee JJ, Cho WS, Kim HA, et al. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes. Rheumatol Int. 2003;23:282–8.CrossRefPubMed
18.
go back to reference Lai EC. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002;30:363–4.CrossRefPubMed Lai EC. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002;30:363–4.CrossRefPubMed
19.
20.
go back to reference Mattes J, Collison A, Foster PS. Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation. Curr Opin Mol Ther. 2008;10:150–7.PubMed Mattes J, Collison A, Foster PS. Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation. Curr Opin Mol Ther. 2008;10:150–7.PubMed
21.
22.
go back to reference Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.CrossRefPubMed Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.CrossRefPubMed
23.
go back to reference Buckland J. Osteoarthritis: microRNA-mediated meniscal injury repair in rats. Nat Rev Rheumatol. 2015;11:64.CrossRefPubMed Buckland J. Osteoarthritis: microRNA-mediated meniscal injury repair in rats. Nat Rev Rheumatol. 2015;11:64.CrossRefPubMed
24.
go back to reference Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, et al. Expression of microRNA‐146a in osteoarthritis cartilage. Arthritis Rheum. 2009;60:1035–41.CrossRefPubMedPubMedCentral Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, et al. Expression of microRNA‐146a in osteoarthritis cartilage. Arthritis Rheum. 2009;60:1035–41.CrossRefPubMedPubMedCentral
25.
go back to reference Le LT, Swingler TE, Clark IM. Review: the role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum. 2013;65:1963–74.CrossRefPubMed Le LT, Swingler TE, Clark IM. Review: the role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum. 2013;65:1963–74.CrossRefPubMed
26.
27.
go back to reference Tsezou A. Osteoarthritis year in review 2014: genetics and genomics. Osteoarthritis Cartilage. 2014;22:2017–24.CrossRefPubMed Tsezou A. Osteoarthritis year in review 2014: genetics and genomics. Osteoarthritis Cartilage. 2014;22:2017–24.CrossRefPubMed
28.
go back to reference Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One. 2008;3:e3740.CrossRefPubMedPubMedCentral Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One. 2008;3:e3740.CrossRefPubMedPubMedCentral
29.
go back to reference Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, Haqqi TM. MicroRNA‐27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010;62:1361–71.CrossRefPubMedPubMedCentral Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, Haqqi TM. MicroRNA‐27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010;62:1361–71.CrossRefPubMedPubMedCentral
30.
go back to reference Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010;24:1173–85.CrossRefPubMedPubMedCentral Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010;24:1173–85.CrossRefPubMedPubMedCentral
32.
go back to reference Tardif G, Hum D, Pelletier JP, Duval N, Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord. 2009;10:148.CrossRefPubMedPubMedCentral Tardif G, Hum D, Pelletier JP, Duval N, Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord. 2009;10:148.CrossRefPubMedPubMedCentral
33.
go back to reference Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005;19:833–42.CrossRefPubMed Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005;19:833–42.CrossRefPubMed
34.
go back to reference Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, et al. The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA. 2009;106:15732–7.CrossRefPubMedPubMedCentral Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, et al. The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA. 2009;106:15732–7.CrossRefPubMedPubMedCentral
35.
go back to reference Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.CrossRefPubMedPubMedCentral Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.CrossRefPubMedPubMedCentral
37.
go back to reference Liang ZJ, Zhuang H, Wang GX, Li Z, Zhang HT, Yu TQ, et al. MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1β-stimulated human articular chondrocyte C28/I2 cells. Inflamm Res. 2012;61:503–9.CrossRefPubMed Liang ZJ, Zhuang H, Wang GX, Li Z, Zhang HT, Yu TQ, et al. MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1β-stimulated human articular chondrocyte C28/I2 cells. Inflamm Res. 2012;61:503–9.CrossRefPubMed
38.
go back to reference Nakamura Y, He X, Kato H, Wakitani S, Kobayashi T, Watanabe S, et al. Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol. 2012;166:64–71.CrossRefPubMedPubMedCentral Nakamura Y, He X, Kato H, Wakitani S, Kobayashi T, Watanabe S, et al. Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol. 2012;166:64–71.CrossRefPubMedPubMedCentral
39.
go back to reference Yang J, Qin S, Yi C, Ma G, Zhu H, Zhou W, et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett. 2011;585:2992–7.CrossRefPubMed Yang J, Qin S, Yi C, Ma G, Zhu H, Zhou W, et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett. 2011;585:2992–7.CrossRefPubMed
40.
go back to reference Yamashita S, Miyaki S, Kato Y, Yokoyama S, Sato T, Barrionuevo F, et al. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem. 2012;287:22206–15.CrossRefPubMedPubMedCentral Yamashita S, Miyaki S, Kato Y, Yokoyama S, Sato T, Barrionuevo F, et al. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem. 2012;287:22206–15.CrossRefPubMedPubMedCentral
41.
go back to reference Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev. 2001;81:1535–65.PubMed Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev. 2001;81:1535–65.PubMed
42.
go back to reference Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science. 1996;273:1222–5.CrossRefPubMed Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science. 1996;273:1222–5.CrossRefPubMed
Metadata
Title
E2 regulates MMP-13 via targeting miR-140 in IL-1β-induced extracellular matrix degradation in human chondrocytes
Authors
Yujie Liang
Li Duan
Jianyi Xiong
Weiming Zhu
Qisong Liu
Daming Wang
Wei Liu
Zigang Li
Daping Wang
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2016
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-016-0997-y

Other articles of this Issue 1/2016

Arthritis Research & Therapy 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.